Citius Pharma

Citius Pharma (CTXR) $1.20. Price Target Upped to $4.00 at HC Wainright.

STREET INSIDER H.C. Wainwright analyst Vernon Bernardino raised the price target on Citius Pharmaceuticals...
Internet Stock Review

Institutional Analyst Newsletters. March.

Internet | Biotech | Beverages | Marijuana | Blockchain The Institutional Analyst newsletter aggregates headlines from all our...
biotech stock review, innovus

Adding Innovus Pharma (INNV) $2.50 to Watch List.

Fast Growing eCommerce and Direct to Consumer Pharma Company Announces 1st Foray into CBD and 2nd Major Off-Patent Blockbuster Drug to its...

Circle Group Holdings (CRGQ) $0.47 Report.

Click to Download. Client, we were compensated with 100,000 shares and warrants to purchase...

Circle Group / Z-Trim (CRGQ/ZTRM) $2.50. Report.

Download Circle Group - Z-Trim Report

Duos Technologies (DOUT) $0.70. Artificial Intelligence Made Easy. Grossly Undervalued.

Internet Stock Review Adds Duos Technologies ($0.70) to Watch List. Graduates to OTCQX 6/20/19. Duos Technologies Website. Presentation...

$230 Million Blank Check! As in blank.

Hats Off to Cantor and Northland Securities for Raising $230 Million to Invest in Something. Not Sure What, Just Something. Something...

Stand Down III: Guess Who This Beautiful Chart Belongs to?

Answer Below.. $14 to $593. That's $140,000 to $5,930,000. That's Real Money.

Latest article

Post Reverse Split, Tharimmune (THAR) Announces Positive Phase I Results.

This is a story of 're-purposed' FDA approved drug, from drug overdose, to a solution for unrelenting itching. If approved, it can...

Trump’s (DJT) up 48% Today

LIVE QUOTE Our only thought is it would be a great idea, to give...

Altamira Thera (CYTO) Explodes 144% Higher Post Reverse Split, With 50 Million Shares Trading...

Taking advantage of post reverse-split investor pessimism, is a VALID investing technique. Altamira is developing and supplying peptide-based...